Trupharma and Harris would not have to add an additional $ to their organisation to market ACR's approved drugs, so first $ straight to their bottom line. Their business model is a portfolio play, so they will sign up dud's, however, any impact is derisked across their portfolio of drugs. If they pay any milestones on FDA approval that may indicate a sentiment of their view on the assets.
Amring as a co-development seems different as they are taking "skin in the game" early which represents risk but a greater slice of the pie later ?? According to the financial report the $300k was for ACR development costs incurred. ACR has stated that the development programs cost between $3-5mil, so a fairway to go for the Amring co-development.
I'm not sure cash will be ok, hope I'm wrong but it maybe managed by slowing down spending on development program which means delays to market.
- Forums
- ASX - By Stock
- ACR
- Why I have bought into ACR
Why I have bought into ACR, page-56
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
|
|||||
Last
6.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.47M |
Open | High | Low | Value | Volume |
6.7¢ | 6.7¢ | 6.5¢ | $2.075K | 31.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 480468 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.7¢ | 41204 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 480468 | 0.065 |
1 | 71240 | 0.064 |
1 | 20918 | 0.063 |
1 | 60640 | 0.062 |
1 | 10000 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.067 | 41204 | 3 |
0.070 | 107594 | 3 |
0.072 | 30000 | 1 |
0.075 | 15000 | 1 |
0.079 | 50000 | 1 |
Last trade - 14.15pm 02/08/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |